SALT LAKE CITY—New products
launched at the USANA Health Sciences Inc. (NASDAQ:USNA) annual convention
helped drive strong domestic sales in all but one of its 12 international
markets, resulting in a 20-percent growth in third quarter net sales to $82.2
million. On the strength of top line growth, net earnings also rose 25.6 percent
to $10.0 million or $0.51 per share, from $8.0 million or $0.39 per share earned
a year ago.
“Buoyed by the success of the convention, U.S. sales, which
represented nearly 43 percent of total sales, grew 22 percent compared with last
year,” said Dave Wentz, president. “In addition, our year-over-year sales
grew in all but one of our markets, and we achieved double-digit growth in many
of our markets. Mexico remained a strong performer during the quarter, with
sales growth of 52 percent, compared with last year.”
Gilbert A. Fuller, chief financial officer (CFO), noted, “Although
our third quarter is customarily our weakest quarter, our sales increased
slightly on a sequential basis and net earnings grew by 5 percent.” Looking
ahead, he added the company (www.usana.com) expects fourth quarter sales to
reach $86 million to $88 million, and anticipates fiscal 2006 growth to be
between 15 percent and 20 percent for both sales and earnings.
Email this article
Add a comment
Printer version
Order reprints
RSS Feed
Bookmark article